-
-
-
-
-
-
-
Coherus Oncology Reports First Quarter 2026 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Coherus Oncology Announces Publication in Molecular Cancer Therapeutics Highlighting the Strong Pharmacology of Investigational CCR8 Antibody Tagmokitug (CHS-114)
-
-
-
-
-
-
-
Coherus Oncology to Report Third Quarter 2025 Financial Results on November 6, 2025
-
-
-
-
-
-
-
Coherus BioSciences (CHRS) announces promising data from CHS-114 trial
-
-
-
-
-
-
-
Coherus BioSciences (CHRS) Tops Q2 EPS by 11c ; Offers Guidance
-
-
-
-
-
-
-
Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights
-
-
-
-
-
-
-
Coherus BioSciences Reports Fourth Quarter and Full Year 2022 Results
-
1,234,721 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


